Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Not applicable Interventional

Creative Art Teletherapy for Veterans With PTSD

ClinicalTrials.gov ID: NCT07840079

Public ClinicalTrials.gov record NCT07840079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This project focuses on how the investigators can treat post-traumatic stress disorder (PTSD) with a Creative Art Teletherapy, Art-therapy Remote Treatment for Veterans Experiencing Trauma (ART-VET). Treatments for PTSD do not work well enough for many Veterans with PTSD. Many patients do not recover with current treatment methods. A core deficit in PTSD is an inability to feel safe in secure environments, and not to have flight, flight, or freeze behaviors. Unfortunately, many people have trouble with exposure-based psychotherapies and have trouble getting better or learning how to feel safer. Also, many rural Veterans are unable to attend treatment sessions in person. The investigators plan to conduct a clinical trial of ART-VET, a promising 8 session (roughly weekly) teletherapy program, and the investigators will measure how well it works using many clinical and research measures before, during, and after participating in the therapy.

Study identification

NCT ID
NCT07840079
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Enrollment
84 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2026
Primary completion
Sep 29, 2030
Completion
Sep 29, 2030
Last update posted
Sep 23, 2026

2026 – 2030

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
North Florida/South Georgia Veterans Health System, Gainesville, FL Gainesville Florida 32608-1135 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07840079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2026 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07840079 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →